Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Notes Payables (2016 - 2025)

INVO Fertility (IVF) has disclosed Notes Payables for 15 consecutive years, with $149293.0 as the latest value for Q3 2025.

  • Quarterly Notes Payables fell 98.0% to $149293.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $149293.0 through Sep 2025, down 98.0% year-over-year, with the annual reading at $880000.0 for FY2024, 68.16% down from the prior year.
  • Notes Payables for Q3 2025 was $149293.0 at INVO Fertility, down from $2.9 million in the prior quarter.
  • The five-year high for Notes Payables was $7.5 million in Q3 2024, with the low at $149293.0 in Q3 2025.
  • Average Notes Payables over 5 years is $2.3 million, with a median of $1.9 million recorded in 2023.
  • The sharpest move saw Notes Payables skyrocketed 375.45% in 2021, then tumbled 98.0% in 2025.
  • Over 5 years, Notes Payables stood at $453406.0 in 2021, then skyrocketed by 68.2% to $762644.0 in 2022, then skyrocketed by 262.41% to $2.8 million in 2023, then plummeted by 68.16% to $880000.0 in 2024, then crashed by 83.03% to $149293.0 in 2025.
  • According to Business Quant data, Notes Payables over the past three periods came in at $149293.0, $2.9 million, and $6.5 million for Q3 2025, Q2 2025, and Q1 2025 respectively.